Global Veterinary Therapeutics Market By Type(Therapeutics drugs, Therapeutics vaccines, Feed additives therapeutics), By End User(Hospitals, Veterinary Clinics, Drugs Stores), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2027
- Published date: Sep 2021
- Report ID: 39586
- Number of Pages: 334
- Format:
- keyboard_arrow_up
- 1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
2.0 Chapter 2
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Type
- 2.2.2 Market Snapshot, By End user
- 2.2.3 Market Snapshot, By Region
3.0 Chapter 3
- 3.1 Global Veterinary Therapeutics Market Dynamics
- 3.1.1 Drivers
- 3.1.2 Restraints
- 3.1.3 Opportunities
- 3.1.4 Trends
- 3.1.5 PEST Analysis
- 3.1.6 PORTER’S Five Forces Analysis
4.0 Chapter 4
- 4.0.1 Global Veterinary Therapeutics Market, by Type
- 4.0.2 Overview
- 4.0.3 Segment Trend
- 4.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 4.1 Therapeutic Drugs
- 4.1.1 Overview
- 4.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 4.2 Therapeutic Vaccines
- 4.2.1 Overview
- 4.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 4.3 Feed Additive Therapeutics
- 4.3.1 Overview
- 4.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
5.0 Chapter 5
- 5.0.1 Global Veterinary Therapeutics Market, by End user
- 5.0.2 Overview
- 5.0.3 Segment Trends
- 5.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 5.1 Hospitals
- 5.1.1 Overview
- 5.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 5.2 Veterinary Clinics
- 5.2.1 Overview
- 5.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 5.3 Drug Stores
- 5.3.1 Overview
- 5.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
6.0 Chapter 6
- 6.0.1 Global Veterinary Therapeutics Market, by Region
- 6.0.2 Overview
- 6.0.3 Regional Trends
- 6.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Million)
- 6.1 Market Share and Forecast, 2016–2026, (Volume in Kg Tons)
- 6.1.1 North America
- 6.1.2 Overview
- 6.1.3 Country Trends
- 6.1.4 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (Value in US$ Million)
- 6.1.5 Market Share and Forecast, 2016–2026, (Volume in Kg Tons)
- 6.1.6 US
- 6.1.7 Canada
- 6.2 Europe
- 6.2.1 Overview
- 6.2.2 Country Trends
- 6.2.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (Value in US$ Million)
- 6.2.4 Market Share and Forecast, 2016–2026, (Volume in Kg Tons)
- 6.2.5 Germany
- 6.2.6 France
- 6.2.7 UK
- 6.2.8 Russia
- 6.2.9 Italy
- 6.2.10 Rest of Europe
- 6.3 Asia Pacific
- 6.3.1 Overview
- 6.3.2 Country Trends
- 6.3.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (Value in US$ Million)
- 6.3.4 Market Share and Forecast, 2016–2026, (Volume in Kg Tons)
- 6.3.5 China
- 6.3.6 Japan
- 6.3.7 South Korea
- 6.3.8 India
- 6.3.9 Southeast Asia (Singapore and Other countries)
- 6.4 South America
- 6.4.1 Overview
- 6.4.2 Country Trends
- 6.4.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (Value in US$ Million)
- 6.4.4 Market Share and Forecast, 2016–2026, (Volume in Kg Tons)
- 6.4.5 Brazil
- 6.4.6 Mexico
- 6.4.7 Rest of South America
- 6.5 Middle East & Africa
- 6.5.1 Overview
- 6.5.2 Country Trends
- 6.5.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (Value in US$ Million)
- 6.5.4 Market Share and Forecast, 2016–2026, (Volume in Kg Tons)
- 6.5.5 GCC
- 6.5.6 Israel
- 6.5.7 South Africa
- 6.5.8 Rest of MEA
7.0 Chapter 7
- 7.0.1 Company Profiles
- 7.0.2 Top US Companies for Veterinary
- 7.0.3 Top Generic US Companies
- 7.1 Bayer AG*
- 7.1.1 Company Overview
- 7.1.2 Product Portfolio
- 7.1.3 Financial Overview
- 7.1.4 Key Developments
- 7.2 Boehringer Ingelheim GmbH
- 7.3 Ceva, Inc.
- 7.4 Dechra Pharmaceuticals PLC
- 7.5 Vetoquinol SA
- 7.6 Zoetis Inc.
- 7.7 Virbac SA
- 7.8 Eli Lilly and Company
- 7.9 Merck Co. Inc.
8.0 Chapter 8
- 8.1 About Us
- 8.2 Research Methodology
- 1.0 Chapter 1
- Bayer AG Company Profile
- Boehringer Ingelheim GmbH
- Ceva, Inc
- Dechra Pharmaceuticals PLC
- Vetoquinol SA
- Zoetis Inc.
- Virbac SA
- Eli Lilly and Company
- Merck Co. Inc.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |